Learn about the Prescription Drug User Fee Act (PDUFA) and its role in supporting the FDA’s review of new therapies. This session explains why PDUFA is important to patients seeking timely access to innovative treatments.
New Name, Same Commitment to Rare Diseases
The EveryLife Foundation for Rare Diseases has become The RARE Foundation! Read more about our new brand and how it unifies our advocacy work on behalf of the rare disease community.
